AGILE THERAPEUTICS INC
Net BuyingAGRX·US·🇺🇸 US
90%buys·10%sales
419 transactions$233.8MTotal buys·82 buys
$7.1MTotal sells·9 sells
4040 insiders
Last: Aug 26, 2024
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Aug 26, 24 | Hubbard John W | Disposition | $1K | |
| Aug 26, 24 | Fischer Seth H.Z. | Disposition | $1K | |
| Aug 26, 24 | ALTOMARI ALFRED | Disposition | $43K | |
| Aug 26, 24 | ALTOMARI ALFRED | Disposition | $30K | |
| Aug 26, 24 | Carson Sandra | Disposition | $1K | |
| Aug 26, 24 | BARBARI SHARON SURREY | Disposition | $1K | |
| Aug 26, 24 | Torrente Josephine | Disposition | $1K | |
| Aug 26, 24 | Torrente Josephine | Disposition | $20 | |
| Aug 26, 24 | Welsh Amy | Disposition | $15K | |
| Aug 26, 24 | Welsh Amy | Disposition | $5K |
AGILE THERAPEUTICS INC (AGRX) has recorded 419 insider transactions from 40 insiders. Total insider buying volume stands at $233.8M, while total selling volume is $7.1M. Overall insider sentiment is bullish (90% purchases).
AGILE THERAPEUTICS INC (AGRX) has recorded 419 insider operations, including 82 open-market purchases ($233.8M), 9 sales ($7.1M) and 328 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (90% purchases).
Recent activity is concentrated over 2 months in the last year.
Among the most active insiders are ALTOMARI ALFRED (CEO), Coiante Scott M (CFO) & Reilly Dennis (CFO), with respectively 111, 31, 25 transactions.
Across all 419 recorded transactions, the breakdown by type is: grant (177, 42%), exercise (108, 26%), buys (82, 20%), other (21, 5%), disposition (18, 4%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
AGILE THERAPEUTICS INC has recorded 419 insider operations in total, including 82 open-market purchases ($233.8M), 9 sales ($7.1M) and 328 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on August 26, 2024.
Insiders at AGILE THERAPEUTICS INC are currently net buyers, with 90% purchases and 10% sales across all reported transactions. Total buy volume is $233.8M versus $7.1M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 40 insiders at AGILE THERAPEUTICS INC (AGRX). ALTOMARI ALFRED (CEO, 111 tx), Coiante Scott M (CFO, 31 tx), Reilly Dennis (CFO, 25 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for AGRX is bullish, based on a 90% buy ratio across 91 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for AGILE THERAPEUTICS INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.